多只，创新高

Group 1 - The core viewpoint is that multiple Hong Kong-themed ETFs have reached historical highs in terms of shares and assets under management, driven by significant capital inflows since 2025 [1][2]. - As of June 17, 2023, the net inflow into Hong Kong-themed ETFs has exceeded 55 billion yuan this year, with a notable increase of over 10 billion yuan compared to the end of last year [2][3]. - Specific ETFs such as the Huatai-PineBridge Hong Kong Innovation Drug ETF and the Yinhua Hong Kong Innovation Drug ETF have seen their shares increase by over 500% and 270% respectively this year, with asset growth exceeding 900% and 500% [3]. Group 2 - Fund companies are intensifying their focus on Hong Kong-themed funds, with 9 out of 85 new funds currently being issued related to Hong Kong, targeting sectors like technology, innovative drugs, and consumption [5][6]. - Major public fund companies are actively launching Hong Kong consumption-themed funds, indicating a strong interest in this market segment [7]. - Future market trends in Hong Kong are expected to be driven by sustained capital inflows, with the valuation of Hong Kong stocks being competitive compared to international markets [7].